CSX

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 3.42 B3.57 B3.59 B3.51 B3.48 B 14.15 B Gross profit 3.15 B3.31 B3.31 B3.24 B3.18 B 13.03 B Operating expenses 2.4 B2.31 B2.51 B2.41 B2.24 B 9.47 B Selling/general/admin expenses 14 M15 M14 M11 M13 M 53 M Research & development ————— — Operating income 1.04 B1.28 B1.09 B1.11 B1.25 B 4.73 B Non-Operating Income, Total 26 M22 M21 M23 M23 M 89 M Interest expense, net of interest capitalized 209 M212 M210 M213 M213 M 848 M Non-Operating Income, excl. Interest Expenses 26 M22 M21 M23 M23 M 89 M Unusual income/expense ————— — Pretax income 858 M1.09 B898 M920 M1.06 B 3.97 B Equity in earnings ————— — Taxes 212 M264 M204 M200 M256 M 924 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 646 M829 M694 M720 M807 M 3.05 B Discontinued operations ————— — Net income 646 M829 M694 M720 M807 M 3.05 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 646 M829 M694 M720 M807 M 3.05 B Basic earnings per share (Basic EPS) 0.340.440.370.390.43 1.63 Diluted earnings per share (Diluted EPS) 0.340.440.370.390.43 1.63 Average basic shares outstanding 1.89 B1.87 B1.86 B1.87 B1.86 B — Diluted shares outstanding 1.89 B1.87 B1.87 B1.87 B1.86 B — EBITDA 1.18 B1.43 B1.22 B1.23 B1.35 B 5.23 B EBIT 752 M999 M792 M829 M938 M 3.56 B Cost of revenue 275 M269 M281 M270 M302 M 1.12 B Other cost of goods sold 275 M269 M281 M270 M302 M 1.12 B Depreciation & amortization (cash flow) 425 M427 M424 M404 M415 M 1.67 B